Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for International Stem Cell (ISCO) over the last 16 years, with Q3 2025 value amounting to $3000.0.

  • International Stem Cell's Capital Expenditures fell 9189.19% to $3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $41000.0, marking a year-over-year decrease of 7515.15%. This contributed to the annual value of $166000.0 for FY2024, which is 10750.0% up from last year.
  • As of Q3 2025, International Stem Cell's Capital Expenditures stood at $3000.0, which was down 9189.19% from $32000.0 recorded in Q2 2025.
  • International Stem Cell's Capital Expenditures' 5-year high stood at $120000.0 during Q2 2024, with a 5-year trough of $1000.0 in Q4 2024.
  • For the 4-year period, International Stem Cell's Capital Expenditures averaged around $26909.1, with its median value being $14000.0 (2023).
  • As far as peak fluctuations go, International Stem Cell's Capital Expenditures skyrocketed by 16428.57% in 2024, and later tumbled by 9189.19% in 2025.
  • International Stem Cell's Capital Expenditures (Quarter) stood at $10000.0 in 2021, then surged by 40.0% to $14000.0 in 2023, then crashed by 92.86% to $1000.0 in 2024, then surged by 200.0% to $3000.0 in 2025.
  • Its Capital Expenditures stands at $3000.0 for Q3 2025, versus $32000.0 for Q2 2025 and $5000.0 for Q1 2025.